Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 196-213
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196
Variable | Patients | FOXM1 expression | P-value | E-cadherin expression | P-value | ||
Low | High | Low | High | ||||
Gender | |||||||
Male | 116 (67) | 48 (41) | 68 (59) | 0.185 | 73 (63) | 43 (37) | 0.187 |
Female | 56 (33) | 17 (30) | 39 (70) | 29 (52) | 27 (48) | ||
Age (yr) | |||||||
≤ 50 | 73 (42) | 24 (33) | 49 (67) | 0.270 | 42 (58) | 31 (42) | 0.754 |
> 50 | 99 (58) | 41 (41) | 58 (59) | 60 (61) | 39 (39) | ||
Underlying liver disease | |||||||
HBV | 133 (69) | 51 (38) | 82 (62) | 0.852 | 80 (60) | 53 (40) | 0.713 |
Others | 39 (31) | 14 (36) | 25 (64) | 22 (56) | 17 (44) | ||
Liver function (Child-Pugh classification) | |||||||
Grade A | 157 (91) | 59 (38) | 98 (62) | 0.720 | 93 (59) | 64 (41) | 0.913 |
Grade B | 11 (6) | 4 (36) | 7 (64) | 7 (64) | 4 (36) | ||
Grade C | 4 (3) | 2 (50) | 2 (50) | 2 (50) | 2 (50) | ||
Preoperative AFP level | |||||||
≤ 200 ng/mL | 66 (42) | 19 (29) | 47 (71) | 0.095 | 40 (61) | 26 (39) | 0.330 |
> 200 ng/mL | 90 (58) | 38 (42) | 52 (58) | 47 (52) | 43 (48) | ||
Tumor size | |||||||
≤ 8 cm | 116 (69) | 52 (45) | 64 (55) | 0.002a | 71 (61) | 45 (39) | 0.611 |
> 8 cm | 51 (31) | 10 (20) | 41 (80) | 29 (57) | 22 (43) | ||
Tumor number | |||||||
≤ 3 | 157 (91) | 64 (40) | 93 (60) | 0.010a | 95 (61) | 62 (39) | 0.410 |
> 3 | 15 (9) | 1 (7) | 14 (93) | 7 (47) | 8 (53) | ||
Cirrhotic background | |||||||
No | 39 (23) | 11 (28) | 28 (72) | 0.191 | 18 (46) | 21 (54) | 0.066 |
Yes | 133 (77) | 54 (41) | 79 (59) | 84 (63) | 49 (37) | ||
Macrovascular invasion | |||||||
No | 149 (87) | 63 (42) | 86 (58) | 0.002a | 82 (55) | 67 (45) | 0.003a |
Yes | 23 (13) | 2 (9) | 21 (91) | 20 (87) | 3 (13) | ||
Tumor differentiation | |||||||
G1/G2 | 154 (94) | 56 (34) | 98 (66) | 0.502 | 87 (56) | 67 (44) | 0.047a |
G3 | 10 (6) | 5 (80) | 5 (20) | 9 (90) | 1 (10) | ||
TNM stage | |||||||
Stage I + II | 135 (78) | 58 (43) | 77 (57) | 0.008a | 73 (53) | 62 (47) | 0.008a |
Stage III (IIIA+IIIB+IIIC) | 37 (22) | 7 (19) | 30 (81) | 29 (78) | 8 (22) |
- Citation: Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(1): 196-213
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/196.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.196